Perforation of gastric metastasis during chemotherapy with ramucirumab

Mayu Kobashi, Hiromitsu Kanzaki, Hiroyuki Okada

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A 59-year-old man received fifth line chemotherapy with ramucirumab and protein-bound paclitaxel for gastric metastasis from esophagogastric junction cancer. On day 3 of the third course, he had severe chest pain and a high fever. Esophagogastroduodenoscopy revealed gastric perforation at the point of the metastatic lesion.

Original languageEnglish
Article number100666
JournalCurrent Problems in Cancer
Issue number2
Publication statusPublished - Apr 2021


  • Chemotherapy
  • Gastric metastasis
  • Gastrointestinal perforation
  • Ramucirumab

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Perforation of gastric metastasis during chemotherapy with ramucirumab'. Together they form a unique fingerprint.

Cite this